{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:58:56Z","timestamp":1793836736401,"version":"4.6.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate long-term recurrence rates and time to first recurrence for human papillomavirus (HPV)\u2013associated high-grade vulvar intraepithelial neoplasia (VIN) by initial treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a retrospective cohort study of patients treated with excision, imiquimod, or laser for HPV-associated VIN grade 2\u20133 at a high-risk colposcopy center. We collected demographic, clinical, and longitudinal pathology data. Given the small number (n=15), the cohort of patients treated with laser were excluded from analyses. We performed \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      and Wilcoxon rank-sum tests to compare the rates of recurrence and median time to first recurrence by treatment modality. Univariate and multivariate analyses were conducted to compare predictors of recurrence and time to recurrence. Multivariate models were adjusted for side effects or barriers to imiquimod use, lesion focality, and initial histology based on significant findings in the univariate models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Three hundred fifteen patients met the criteria for inclusion, 231 treated with excision and 84 with imiquimod. Median follow-up time from initial diagnosis was 36 months. Recurrence rates and median time to recurrence with imiquimod (40.5% and 7.4 months) and excision (34.6% and 11.3 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.34,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.38) did not differ significantly. In univariate analysis, positive margins (odds ratio [OR] 4.68, 95% CI, 2.53\u20138.62), multifocal disease (OR 2.27, 95% CI, 1.19\u20134.33), and presence of carcinoma in situ on initial diagnosis (OR 6.21, 95% CI, 1.45\u201326.6) were predictors of recurrence after excision. Only the presence of side effects or barriers to imiquimod use (OR 2.46, 95% CI, 1.01\u20136.02) was significant in the univariate model for recurrence after imiquimod. No significant difference remained for the odds of recurrence after treatment with imiquimod compared with excision in the multivariate model (OR 1.28, 95% CI, 0.77\u20132.14); there was similarly no significant difference in the multivariate model of time to recurrence (hazard ratio 1.41, 95% CI, 0.86\u20132.30).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In appropriately selected patients, imiquimod appears to have outcomes similar to those of excision for the prevention of recurrent HPV-associated VIN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006094","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T21:00:40Z","timestamp":1760648440000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Recurrence of High-Grade Vulvar Intraepithelial Neoplasia After Treatment With Excision Compared With Imiquimod"],"prefix":"10.1097","volume":"147","author":[{"given":"Hadley","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Hsu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk On Annie","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Parra","family":"Herran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"R1-20260824","first-page":"e178","article-title":"Management of vulvar intraepithelial neoplasia, Committee Opinion No.675 [published erratum appears in Obstet Gynecol 2017;129:209]. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R2-20260824","first-page":"CD011837","article-title":"Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia","volume":"1","author":"Lawrie","year":"2016","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3802\/jgo.2013.24.3.236","article-title":"Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia","volume":"24","author":"Fehr","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"R5-20260824","first-page":"23","article-title":"Pilot study of sexual function and quality of life after excision for vulvar intraepithelial neoplasia","volume":"52","author":"Likes","year":"2007","journal-title":"J Reprod Med"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/01443610903191285","article-title":"The prospective management of women with newly diagnosed vulval intraepithelial neoplasia: clinical outcome and quality of life","volume":"29","author":"McFadden","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajog.2014.05.039","article-title":"Does treatment for cervical and vulvar dysplasia impact women's sexual health?","volume":"212","author":"Cendejas","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.33198","article-title":"Vulvar intraepithelial neoplasia: incidence and long\u2010term risk of vulvar squamous cell carcinoma","volume":"148","author":"Thuijs","year":"2021","journal-title":"Int J Cancer"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2012.07.118","article-title":"Vulvar intraepithelial neoplasia (VIN 2\/3): comparing clinical outcomes and evaluating risk factors for recurrence","volume":"127","author":"Wallbillich","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-0528.1996.tb09771.x","article-title":"Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women","volume":"103","author":"Herod","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(22)00469-X","article-title":"Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial","volume":"399","author":"Trutnovsky","year":"2022","journal-title":"Lancet"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/LGT.0b013e318196bd23","article-title":"Vulvar intraepithelial neoplasia 3 in women less than 35 years","volume":"13","author":"Kesterson","year":"2009","journal-title":"J Low Genit Tract Dis"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2017.10.029","article-title":"Vulvar intraepithelial neoplasia: risk factors for recurrence","volume":"148","author":"Satmary","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-20260824","first-page":"962","article-title":"Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence","volume":"92","author":"Modesitt","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"90","DOI":"10.14740\/wjon1743","article-title":"Multicentricity and the risk of recurrence\/persistence after laser vaporization for high-grade vulvar and vaginal intraepithelial neoplasia","volume":"15","author":"Boonlikit","year":"2024","journal-title":"World J Oncol"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2007.05.019","article-title":"Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia","volume":"106","author":"Le","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S1470-2045(14)70456-5","article-title":"Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial","volume":"15","author":"Tristram","year":"2014","journal-title":"Lancet Oncol"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens","volume":"138","author":"Shumack","year":"2002","journal-title":"Arch Dermatol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:05:36Z","timestamp":1787573136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006094","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"2025-05-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}